131 related articles for article (PubMed ID: 15099492)
1. [Current strategy of prevention and treatment of obesity-related liver disease].
Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):255-6. PubMed ID: 15099492
[No Abstract] [Full Text] [Related]
2. Management of nonalcoholic fatty liver disease: weight control.
Bouneva I; Kirby DF
Clin Liver Dis; 2004 Aug; 8(3):693-713, xii. PubMed ID: 15331070
[TBL] [Abstract][Full Text] [Related]
3. [The liver in untreated and treated obesity].
Andersen T; Gluud C
Ugeskr Laeger; 1984 Oct; 146(40):3011-4. PubMed ID: 6515933
[No Abstract] [Full Text] [Related]
4. The enlarging body of evidence: obesity and chronic kidney disease.
Chertow GM; Hsu CY; Johansen KL
J Am Soc Nephrol; 2006 Jun; 17(6):1501-2. PubMed ID: 16672317
[No Abstract] [Full Text] [Related]
5. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
6. Is liver disease a threat to patients with metabolic disorders?
Marchesini G; Forlani G; Bugianesi E
Ann Med; 2005; 37(5):333-46. PubMed ID: 16179269
[TBL] [Abstract][Full Text] [Related]
7. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment.
Daniels SR; Arnett DK; Eckel RH; Gidding SS; Hayman LL; Kumanyika S; Robinson TN; Scott BJ; St Jeor S; Williams CL
Circulation; 2005 Apr; 111(15):1999-2012. PubMed ID: 15837955
[TBL] [Abstract][Full Text] [Related]
8. Current perspectives of obesity and its treatment.
Khaodhiar L; Apovian CM
Manag Care Interface; 2007 May; 20(5):24-31. PubMed ID: 17626588
[TBL] [Abstract][Full Text] [Related]
9. Treatment modalities of obesity: what fits whom?
Hainer V; Toplak H; Mitrakou A
Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
[TBL] [Abstract][Full Text] [Related]
10. [Electroacupuncture for treatment of simple obesity complicated with fatty liver].
Jiao L; Chi ZH
Zhongguo Zhen Jiu; 2008 Mar; 28(3):183-6. PubMed ID: 18447216
[TBL] [Abstract][Full Text] [Related]
11. The CARI guidelines. Prevention of progression of kidney disease: weight reduction in obese patients with chronic kidney disease.
Thomas MC;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S49-51. PubMed ID: 17316281
[No Abstract] [Full Text] [Related]
12. Obesity and cancer.
Brawer R; Brisbon N; Plumb J
Prim Care; 2009 Sep; 36(3):509-31. PubMed ID: 19616153
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of obesity-related hypertension].
Skoczylas A
Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
[TBL] [Abstract][Full Text] [Related]
14. Morbid obesity and gross malnutrition are both poor predictors of outcomes after liver transplantation: what can we do about it?
Thuluvath PJ
Liver Transpl; 2009 Aug; 15(8):838-41. PubMed ID: 19642129
[No Abstract] [Full Text] [Related]
15. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.
Rosengren A; Hauptman PJ; Lappas G; Olsson L; Wilhelmsen L; Swedberg K
Eur Heart J; 2009 May; 30(9):1113-20. PubMed ID: 19304990
[TBL] [Abstract][Full Text] [Related]
16. Obesity and cancer treatment: weighing the evidence.
Griggs JJ; Sabel MS
J Clin Oncol; 2008 Sep; 26(25):4060-2. PubMed ID: 18757320
[No Abstract] [Full Text] [Related]
17. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
[TBL] [Abstract][Full Text] [Related]
18. Weight parameters and pathological eating as predictors of obesity treatment outcome in children and adolescents.
Goossens L; Braet C; Van Vlierberghe L; Mels S
Eat Behav; 2009 Jan; 10(1):71-3. PubMed ID: 19171325
[TBL] [Abstract][Full Text] [Related]
19. Future and implications of reimbursement for obesity treatment.
Stern JS; Kazaks A; Downey M
J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S104-9. PubMed ID: 15867905
[TBL] [Abstract][Full Text] [Related]
20. Hepatic complications of obesity.
Diehl AM
Gastroenterol Clin North Am; 2005 Mar; 34(1):45-61. PubMed ID: 15823438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
